Tag: Aducanumab

Blog – Alzheimer’s treatments: Game-changers or false hope?

Guest blog

Blog – Alzheimer’s treatments: Game-changers or false hope?

23/10/2023 Dr Kamar Ameen-Ali

Drilling Down into the CMS Aduhelm Decision

Research News

Drilling Down into the CMS Aduhelm Decision

26/04/2022 Alz Forum

Donanemab Puts Plasma p-Tau, Remote Assessments to the Test

Science

Donanemab Puts Plasma p-Tau, Remote Assessments to the Test

23/11/2021 Dementia Researcher

On Donanemab, Plaques Plummet. Off Donanemab, They Stay Away

Partner Blogs, Science

On Donanemab, Plaques Plummet. Off Donanemab, They Stay Away

18/08/2021 Alz Forum

Blog – The Aduhelm Paradox

Guest blog, Science

Blog – The Aduhelm Paradox

04/07/2021 Dr Sam Moxon

Clinicians respond to Aducanumab news

Research News

Clinicians respond to Aducanumab news

24/06/2021 Alz Forum

Biogen Aducanumab drug approved by FDA

Research News

Biogen Aducanumab drug approved by FDA

07/06/2021 Dementia Researcher

Biogen Asks FDA To Approve Aducanumab

Dissemination

Biogen Asks FDA To Approve Aducanumab

09/07/2020 Alz Forum